Skip to main content
. 2021 Dec 13;193(49):E1868–E1877. doi: 10.1503/cmaj.202783

Table 1:

SARS-CoV-2 antibody seroprevalence by participant characteristics

Characteristic Category No. (%) of participants
n = 2056
No. (%) of participants with positive serology
n = 241
Seroprevalence, % p value
Regional incidence of COVID-19* High 1630 (79.3) 228 (94.6) 14.0 < 0.001
Low 426 (20.7) 13 (5.4) 3.1
Work in a hospital where outbreaks occurred Yes 789 (38.4) 179 (74.3) 22.7 < 0.001
No 1267 (61.6) 62 (25.7) 4.9
Recruitment unit Emergency department 600 (29.2) 47 (19.5) 7.8 < 0.001
Intensive care unit 470 (22.9) 29 (12.0) 6.2
COVID-19 unit 496 (24.1) 99 (41.1) 20.0
Non–COVID-19 unit 490 (23.8) 66 (27.4) 13.5
Main work unit Emergency department 580 (28.2) 46 (19.1) 7.9 < 0.001
Intensive care unit 469 (22.8) 29 (12.0) 6.2
COVID-19 unit 436 (21.2) 101 (42.0) 23.2
Non–COVID-19 unit 438 (21.3) 51 (21.2) 11.6
Other 133 (6.5) 14 (5.8) 10.5
Age group, yr 18–29 427 (20.8) 41 (17.0) 9.6 0.6
30–39 643 (31.3) 78 (32.4) 12.1
40–49 547 (26.6) 70 (29.0) 12.8
50–59 356 (17.3) 43 (17.8) 12.1
≥ 60 83 (4.0) 9 (3.7) 10.8
Occupation Physician 432 (21.0) 31 (12.9) 7.2 0.007
Nurse 1189 (57.8) 141 (58.5) 11.9
Nursing assistant 132 (6.4) 22 (9.1) 16.7
Orderly 201 (9.8) 36 (14.9) 17.9
Cleaning staff 102 (5.0) 11 (4.6) 10.8
Sex Male 489 (23.8) 51 (21.2) 10.4 0.3
Female 1564 (76.1) 189 (78.4) 12.1
Missing§ 3 (0.1)
Born in Canada Yes 1548 (75.3) 154 (63.9) 9.9 < 0.001
No 503 (24.5) 86 (35.7) 17.1
Missing 5 (0.2)
Ethnicity White 1594 (77.5) 163 (67.6) 10.2 < 0.001
Black 140 (6.8) 31 (12.9) 22.1
Hispanic 52 (2.5) 14 (5.8) 26.9
Other 270 (13.1) 33 (13.7) 12.2
Household 1 adult, no child 328 (16.0) 31 (12.9) 9.5 0.009
2 adults, no child 480 (23.3) 54 (22.4) 11.3
≥ 3 adults, no child 234 (11.4) 35 (14.5) 15.0
1 adult, ≥ 1 children 155 (7.5) 27 (11.2) 17.4
2 adults, ≥ 1 children 672 (32.7) 64 (26.6) 9.5
≥3 adults, ≥ 1 children 187 (9.1) 30 (12.4) 16.0
PCR test for SARS-CoV-2 Yes, positive result 193 (9.4) 171 (71.0) 88.6 < 0.001
Yes, negative result 929 (45.2) 50 (20.7) 5.4
No 932 (45.3) 20 (8.3) 2.1
Missing§ 2 (0.1)
COVID-19-congruent symptoms** Yes 768 (37.4) 186 (77.2) 24.2 < 0.001
No 1242 (60.4) 53 (22.0) 4.3
Missing§ 46 (2.2)
Chronic disease Yes 286 (13.9) 37 (15.4) 12.9 0.5
No 1755 (85.4) 202 (83.8) 11.5
Missing§ 15 (0.7)
Experience in the hospital Less than 1 year 179 (8.7) 19 (7.9) 10.6 0.4
1 to 4 year 526 (25.6) 70 (29.0) 13.3
≥ 5 year 1346 (65.5) 151 (62.7) 11.2
Missing§ 5 (0.2)
Primary work shift Day 1330 (64.7) 159 (66.0) 12.0 0.3
Evening 417 (20.3) 54 (22.4) 12.9
Night 289 (14.1) 27 (11.2) 9.3
Missing§ 20 (1.0)
Mean weekly number of workdays ≤ 2 87 (4.2) 5 (2.1) 5.7 0.09
≥ 3 1958 (95.2) 235 (97.5) 12.0
Missing§ 11 (0.5)
Mean weekly number of workdays in a hot zone†† ≤ 2 743 (36.1) 60 (24.9) 8.1 < 0.001
≥ 3 1233 (60.0) 173 (71.8) 14.0
Missing§ 80 (3.9)
Work at another site Yes, including long-term care 100 (4.9) 16 (6.6) 16.0 0.3
Yes, no long-term care 194 (9.4) 19 (7.9) 9.8
No 1757 (85.5) 204 (84.6) 11.6
Missing§ 5 (0.2)
Worked in a unit affected by a COVID-19 outbreak Never 742 (36.1) 36 (14.9) 4.9 < 0.001
Rarely 223 (10.8) 29 (12.0) 13.0
Sometimes 281 (13.7) 39 (16.2) 13.9
Regularly 561 (27.3) 114 (47.3) 20.3
Do not know 245 (11.9) 22 (9.1) 10.0
Missing§ 4 (0.2)
Removal from work because of a close contact with a COVID-19 case Yes, family contact 44 (2.1) 12 (5.0) 27.3 < 0.001
Yes, work contact‡‡ 212 (10.3) 81 (33.6) 38.2
Yes, other contact 29 (1.4) 3 (1.2) 10.3
No 1751 (85.2) 138 (57.3) 7.9
Missing§ 20 (1.0)

Note: PCR = polymerase chain reaction.

*

Incidence of COVID-19 in the region where the hospital is located (high = Montréal region; low = Capitale-Nationale and Eastern Townships regions).

Hospitals where an outbreak (involving ≥ 5 health care workers) occurred in 1 or more units targeted for recruitment.

Participant works in other type of units or in different units (e.g., roving team).

§

Missing = Do not know, prefer not to answer or missing value.

Includes Asian (n = 114, seroprevalence 12.3%), Middle Eastern (n = 53, seroprevalence 13.2%), other category (n = 34, seroprevalence 14.7%), answered more than 1 category (n = 46, seroprevalence 8.7%), prefer not to answer/do not know (n = 23, seroprevalence 21.7%). Fewer than 1% of participants (n = 4) preferred not to answer.

**

Occurrence of any symptom congruent with COVID-19 since Mar. 1, 2020 (i.e., fever, generalized malaise, extreme fatigue, cough, breathing difficulties, sore throat, loss of smell, loss of taste or diarrhea).

††

Zone where patients are positive for SARS-CoV-2.

‡‡

Contact with a patient or another health care worker.